256 related articles for article (PubMed ID: 30421506)
1. Potentiation of paclitaxel effect by resveratrol in human breast cancer cells by counteracting the 17β-estradiol/estrogen receptor α/neuroglobin pathway.
Cipolletti M; Montalesi E; Nuzzo MT; Fiocchetti M; Ascenzi P; Marino M
J Cell Physiol; 2019 Apr; 234(4):3147-3157. PubMed ID: 30421506
[TBL] [Abstract][Full Text] [Related]
2. Neuroglobin overexpression induced by the 17β-Estradiol-Estrogen receptor-α Pathway reduces the sensitivity of MCF-7 Breast cancer cell to paclitaxel.
Fiocchetti M; Cipolletti M; Leone S; Ascenzi P; Marino M
IUBMB Life; 2016 Aug; 68(8):645-51. PubMed ID: 27312786
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the 17β-estradiol pathways necessary for neuroglobin anti-apoptotic activity in breast cancer.
Fiocchetti M; Cipolletti M; Ascenzi P; Marino M
J Cell Physiol; 2018 Jul; 233(7):5087-5103. PubMed ID: 29219195
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway.
Montalesi E; Cracco P; Acconcia F; Fiocchetti M; Iucci G; Battocchio C; Orlandini E; Ciccone L; Nencetti S; Muzzi M; Moreno S; Venditti I; Marino M
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768470
[TBL] [Abstract][Full Text] [Related]
5. Neuroglobin, a pro-survival player in estrogen receptor α-positive cancer cells.
Fiocchetti M; Nuzzo MT; Totta P; Acconcia F; Ascenzi P; Marino M
Cell Death Dis; 2014 Oct; 5(10):e1449. PubMed ID: 25299774
[TBL] [Abstract][Full Text] [Related]
6. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
[TBL] [Abstract][Full Text] [Related]
7. Neuroglobin upregulation induced by 17β-estradiol sequesters cytocrome c in the mitochondria preventing H2O2-induced apoptosis of neuroblastoma cells.
De Marinis E; Fiocchetti M; Acconcia F; Ascenzi P; Marino M
Cell Death Dis; 2013 Feb; 4(2):e508. PubMed ID: 23429294
[TBL] [Abstract][Full Text] [Related]
8. Neuroglobin As Key Mediator in the 17β-Estradiol-Induced Antioxidant Cell Response to Oxidative Stress.
Solar Fernandez V; Cipolletti M; Ascenzi P; Marino M; Fiocchetti M
Antioxid Redox Signal; 2020 Feb; 32(4):217-227. PubMed ID: 31686530
[No Abstract] [Full Text] [Related]
9. Resveratrol and 3,3'-Diindolylmethane Differentially Regulate Aryl Hydrocarbon Receptor and Estrogen Receptor Alpha Activity through Multiple Transcriptomic Targets in MCF-7 Human Breast Cancer Cells.
Das S; Somisetty VS; Ulven SM; Matthews J
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834026
[TBL] [Abstract][Full Text] [Related]
10. ERβ-dependent neuroglobin up-regulation impairs 17β-estradiol-induced apoptosis in DLD-1 colon cancer cells upon oxidative stress injury.
Fiocchetti M; Camilli G; Acconcia F; Leone S; Ascenzi P; Marino M
J Steroid Biochem Mol Biol; 2015 May; 149():128-37. PubMed ID: 25683270
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death.
Sui M; Huang Y; Park BH; Davidson NE; Fan W
Cancer Res; 2007 Jun; 67(11):5337-44. PubMed ID: 17545614
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
Chang J; Sui M; Fan W
Breast Cancer Res Treat; 2012 Aug; 134(3):969-80. PubMed ID: 22374518
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol regulates the cell viability promoted by 17β-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor α and insulin growth factor-1 receptor in BG-1 ovarian cancer cells.
Kang NH; Hwang KA; Lee HR; Choi DW; Choi KC
Food Chem Toxicol; 2013 Sep; 59():373-9. PubMed ID: 23810794
[TBL] [Abstract][Full Text] [Related]
15. Proteomic and Bioinformatic Investigation of Altered Pathways in Neuroglobin-Deficient Breast Cancer Cells.
Costanzo M; Fiocchetti M; Ascenzi P; Marino M; Caterino M; Ruoppolo M
Molecules; 2021 Apr; 26(8):. PubMed ID: 33924212
[TBL] [Abstract][Full Text] [Related]
16. Unexpected Impact of a Hepatitis C Virus Inhibitor on 17β-Estradiol Signaling in Breast Cancer.
Bartoloni S; Leone S; Acconcia F
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32408555
[TBL] [Abstract][Full Text] [Related]
17. Posttranscriptional Control of PD-L1 Expression by 17β-Estradiol via PI3K/Akt Signaling Pathway in ERα-Positive Cancer Cell Lines.
Yang L; Huang F; Mei J; Wang X; Zhang Q; Wang H; Xi M; You Z
Int J Gynecol Cancer; 2017 Feb; 27(2):196-205. PubMed ID: 27870715
[TBL] [Abstract][Full Text] [Related]
18. The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells.
Jiang Z; Guo J; Shen J; Jin M; Xie S; Wang L
J Exp Clin Cancer Res; 2012 May; 31(1):42. PubMed ID: 22553917
[TBL] [Abstract][Full Text] [Related]
19. ERalpha signaling through slug regulates E-cadherin and EMT.
Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
[TBL] [Abstract][Full Text] [Related]
20. Isobavachalcone sensitizes cells to E2-induced paclitaxel resistance by down-regulating CD44 expression in ER+ breast cancer cells.
Shi J; Chen Y; Chen W; Tang C; Zhang H; Chen Y; Yang X; Xu Z; Wei J; Chen J
J Cell Mol Med; 2018 Nov; 22(11):5220-5230. PubMed ID: 30179299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
